Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 19, 2025 • 3:00 AM ET

Date/Time Source News Release
01/21/2025 08:30 AM EST GlobeNewswire Nascent Biotech Receives Delinquency Notification Related to its Delayed September 30, 2024 Financial Filing
07/30/2024 08:00 AM EDT ACCESSWIRE Nascent Biotech Presents at the July Emerging Growth Conference
07/17/2024 07:00 AM EDT GlobeNewswire Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
04/16/2024 08:00 AM EDT ACCESSWIRE Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run
03/19/2024 08:00 AM EDT ACCESSWIRE Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System
02/06/2024 07:00 AM EST ACCESSWIRE Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates
01/09/2024 08:00 AM EST ACCESSWIRE Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valued
12/19/2023 08:00 AM EST ACCESSWIRE Nascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution Risk
11/29/2023 08:00 AM EST ACCESSWIRE Nascent Biotech Granted Japanese Patent for Crossing Blood-Brain Barrier
08/22/2023 08:00 AM EDT ACCESSWIRE Nascent Biotech to Begin Phase II Clinical Trials for Brain Cancer
Page

Additional News

As of June 19, 2025 • 3:00 AM ET

Date/Time Source News Release
01/21/2025 09:05 AM EST SeekingAlpha Nascent Biotech receives delinquency notification related to delayed filing
04/16/2024 08:17 AM EDT SeekingAlpha Nascent Biotech prepares for pivotal Phase II research with fresh manufacturing run
03/19/2024 08:34 AM EDT SeekingAlpha Nascent Biotech partners with Hypospray Pharma for transdermal delivery system
05/10/2023 04:59 AM EDT Wall Street PR News Why Biotech Sleeper NBIO Could be Nearing its Wake-Up Call
03/21/2023 07:55 AM EDT Wall Street PR News NBIO Vies for Phase II Kick-Off After 8yr Journey with Unique Cancer Treatment
02/08/2023 07:29 AM EST Wall Street PR News NBIO Flying Under the Radar Ahead of Potential Major Catalyst
01/18/2023 07:06 AM EST Wall Street PR News NBIO Fits Profile for Strategy Targeting Early Stage Biotech
11/30/2022 06:50 AM EST Wall Street PR News Fishing for Bargains... Nascent Biotech (OTCMKTS:NBIO) Ripe for Acquisition?
11/15/2022 08:35 AM EST Wall Street PR News Nascent Biotech Inc (OTCMKTS:NBIO) Continues to Build a Strong Case
11/01/2022 09:45 AM EDT SeekingAlpha Nascent to get US patent linked to brain cancer drug pritumumab
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.